Return to study ST001236 main page
MB Sample ID: SA088537
| Local Sample ID: | CA209009-3-15_week 4 |
| Subject ID: | SU001304 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR001319 |
| Treatment Summary: | In CA209-009, NCT01358721, Nivolumab was administered intravenously every 3 weeks at 0.3, 2, or 10 mg/kg to previously treated patients and 10 mg/kg to treatment-naïve patients with metastatic renal cell carcinoma (mRCC). |
| Treatment Protocol ID: | NCT01358721 |
